Santa Ana Bio
↗Alameda, USA
Santa Ana Bio is a precision immunology company dedicated to developing targeted therapies for patients with autoimmune and inflammatory diseases. The company utilizes a proprietary multi-omics platform—incorporating proteomics, transcriptomics, and genomics—to identify disease-specific cell subpopulations and targets that are unique to pathogenic cells while sparing healthy tissue.
By leveraging advanced protein engineering capabilities, including monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates (ADCs), Santa Ana Bio aims to overcome the limitations of current biologics, such as patient heterogeneity and safety concerns. The company was founded by Versant Ventures and is led by a team of industry veterans with deep expertise in immunology and drug development.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:Pre-revenue
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$168M
Investors:Versant Ventures, GV (Google Ventures), TPG Life Science Innovations, Access Biotechnology, Andreessen Horowitz (a16z) Bio + Health, RTW Investments
PIPELINE
Stage:Preclinical
Lead Drug Stage:IND-enabling
Modalities:mAb, Bispecific antibody, ADC
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Versant Ventures (Founding partner), LatchBio (Computational biology infrastructure)
COMPETITION
Position:Emerging
Competitors:Kyverna Therapeutics, Sonoma Biotherapeutics, Quell Therapeutics, Granite Bio
LEADERSHIP
Key Executives:
Peter Emtage - Founder & CEO
Newman Yeilding - Chief Medical Officer
Neil Abdollahian - Chief Business Officer
Scientific Founders:Peter Emtage, Danny Wells
Board Members:Mike W. Bonney (Chair), Jerel Davis (Versant Ventures), Brendan Bulik-Sullivan (GV), Vineeta Agarwala (a16z)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Santa Ana Bio. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.